Get startedLog in
    Picture of China Resources Pharmaceutical logo

    3320 — China Resources Pharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareBalancedLarge CapContrarian
    All News

    Brief: China Resources Pharmaceutical Group Posts H1 Net Income RMB 5,053.6 Million

    Picture of China Resources Pharmaceutical logoChina Resources Pharmaceutical
    26/08/2025 05:12
    Aug 26 (Reuters) - China Resources Pharmaceutical 3320.HK:

H1 GROSS MARGIN 16.3%

H1 GROSS PROFIT RMB 21,509.6 MILLION

H1 NET INCOME RMB 5,053.6 MILLION

H1 REVENUE RMB 131,866.8 MILLION

DECLARE INTERIM DIVIDEND OF RMB0.072 PER ORDINARY SHARE

Further company coverage: 3320.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Resources Pharmaceutical

    See all news